Nordicus Partners Corp financial data

Symbol
NORD on OTC
Industry
Services-Management Consulting Services
Location
280 South Beverly Dr., Suite 505, Beverly Hills, CA
State of incorporation
Delaware
Fiscal year end
March 31
Former names
EKIMAS Corp (to 5/3/2023), AdvanSource Biomaterials Corp (to 4/3/2020), CARDIOTECH INTERNATIONAL INC (to 9/8/2008)
Latest financial report
10-Q - Q2 2024 - Aug 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99.8 % +26.7%
Debt-to-equity 0.72 % -88.8%
Return On Equity -8.24 % +98.8%
Return On Assets -7.89 % +98.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.6M shares +356%
Common Stock, Shares, Outstanding 5.68M shares +0.03%
Entity Public Float 5.59M USD +765%
Common Stock, Value, Issued 49.5K USD +358%
Weighted Average Number of Shares Outstanding, Basic 31.3M shares +265%
Weighted Average Number of Shares Outstanding, Diluted 31.3M shares +265%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 82.6K USD -55.3%
Operating Income (Loss) -514K USD +85.3%
Nonoperating Income (Expense) -1.91K USD -134%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -516K USD +85.2%
Net Income (Loss) Attributable to Parent -516K USD +85.2%
Earnings Per Share, Basic -0.04 USD/shares +92.6%
Earnings Per Share, Diluted -0.04 USD/shares +92.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 38.8K USD +676%
Assets, Current 80.4K USD +145%
Goodwill 18.6M USD
Other Assets, Noncurrent 318K USD +11931%
Assets 20.8M USD +1065%
Contract with Customer, Liability, Current 7.5K USD
Liabilities, Current 65.2K USD +181%
Liabilities 65.2K USD +181%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.08K USD -610%
Retained Earnings (Accumulated Deficit) -44.1M USD -4.51%
Stockholders' Equity Attributable to Parent 19.8M USD +1023%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 27.7K USD
Liabilities and Equity 20.8M USD +1065%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -218K USD
Net Cash Provided by (Used in) Financing Activities 60K USD +140%
Net Cash Provided by (Used in) Investing Activities 135K USD
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 49.5M shares +358%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -60K USD +24.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.7K USD -16.6%
Deferred Tax Assets, Valuation Allowance 2.38M USD +2.69%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.27 pure 0%
Deferred Tax Assets, Gross 3.18M USD +9.91%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -520K USD +85.1%
Deferred Tax Assets, Operating Loss Carryforwards 2.38M USD +2.69%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 63.9M USD +45.3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.18M USD +9.91%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%